This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Legionnaire Disease Testing Market

Market Insights on Legionnaire Disease Testing covering sales outlook, demand forecast & up-to-date key trends

Legionnaire Disease Testing Market by Product Type, Diagnostic Test, End User & Region - Forecast 2022 – 2032

Legionnaire Disease Testing Market Outlook

[342 Pages Report] The legionnaire disease testing market is projected to register a CAGR of 9% during the forecast period, up from US$ 292 Mn in 2022 to reach a valuation of US$ 819.5 Mn by 2032.

The legionnaire disease testing market is anticipated to show promising growth prospects during the forecast period as a result of growing competition. New competitors are offering a variety of options at reasonable pricing to fulfil the demand for legionnaire disease testing making it more accessible to customers in the global legionnaire disease testing market.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 267 Million

Expected Market Value (2022)

US$ 292 Million

Anticipated Forecast Value (2032)

US$ 819.5 Million

Projected Growth Rate (2022-2032)

 9% CAGR

Sales of legionnaire disease testing are expected to rise significantly. In addition to this, sales of legionnaire disease testing are rising on account for US$ 411.3 Mn by 2026. Increasing sales of legionnaire disease testing  are also projected to contribute to the growth of the legionnaire disease testing market share.

Increasing public knowledge about effective illness detection and management has resulted from increased government programmes and financing. Furthermore, the worldwide legionnaire disease testing market is being driven by an increase in the need for better diagnostic methods as the prevalence rate rises.

The legionnaire illness testing market may expand as the adoption rate of legionnaire disease testing rises. The legionnaire disease testing market is also predicted to rise due to increased R&D initiatives for technology development for different illnesses.

The shortage of qualified specialists, on the other hand, is likely to stifle the legionnaire disease testing market expansion. Lack of resources and ignorance about infection are also predicted to stymie the sales of legionnaire disease testing market expansion.

Manufacturers in the legionnaire disease testing market get a big platform from which to serve the whole demand for legionnaire disease testing. The worldwide sales of legionnaire disease testing is seeing increased competition. With growing competition, new competitors are offering a variety of options at reasonable pricing, fulfilling the demand for legionnaire disease testing more accessible to customers.

Some of the key players present in the global legionnaire disease testing market are Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; F. Hoffmann-La Roche AG; Thermo Fischer Scientific, Inc.; Becton, Dickinson and Company; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Drivers to the Legionnaire Disease Testing Market Share?

According to the World Health Organization, 75-80% of the population is 50 years old or older, with 65-70% of the population being male. The male population is more susceptible to the demand for legionnaire disease testing than the female population.

Furthermore, the elderly are at a higher risk of legionnaire disease testing and are more likely to get infected. Globally, however, the advancement of innovative testing technologies is increasing. Increased knowledge of present and evolving technology is also helping to boost acceptance of the new testing method, which is projected to open up significant sales of legionnaire disease testing.

However, a scarcity of qualified healthcare providers, as well as a lack of knowledge of the condition and the inability to diagnose it at an early stage, may stymie the demand for legionnaire disease testing market expansion. Furthermore, the absence of improved healthcare facilities may limit the legionnaire disease testing market growth.

Which is the Leading Region in the Legionnaire Disease Testing Market?

The sales of legionnaire disease testing market in Asia-Pacific are predicted to expand rapidly in the next years. This is owing to the existence of a huge population of people who are at high risk. In addition, a lack of knowledge on how to treat infectious diseases is adding to the region's growing population at risk.

The legionnaire disease testing market is predicted to increase rapidly as a result of this. Because of the region's excellent healthcare infrastructure and extensive research and development activities, the North American legionnaire disease testing market is likely to be the most prominent. Due to the availability of qualified researchers and a strong acceptance rate in the area, Europe will rank second in the sales of legionnaire disease testing market.

Due to a scarcity of qualified specialists in the region, the legionnaire disease testing market in Latin America is predicted to rise steadily. Due to a lack of facilities and public knowledge of legionnaire illness, the Middle East and Africa are likely to be the least profitable hence a decline in the demand for legionnaire disease testing.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Players in the Legionnaire Disease Testing Market?

The report consists of key players, contributing to the legionnaire disease testing market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyzes the competitive landscape and legionnaire disease testing market share acquired by players to strengthen their market position.

Some of the key players present in the global legionnaire disease testing market are Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; F. Hoffmann-La Roche AG; Thermo Fischer Scientific, Inc.; Becton, Dickinson and Company; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others.

Recent developments of the Legionnaire Disease Testing Market

  • June 2021 - Phigenics has unveiled a new diagnostic tool. To detect Legionella serogroup and species in building water systems, Phigenics Validation Test (PVT) Next Day LegiPlex PCR (Polymerase Chain Reaction). It provides quick findings, and the test met the International Standards Organization's (ISO) requirements for a limit of detection and specificity.
  • March 2021 – IDEXX released the findings of research conducted by WLN, a water quality and technology firm. The IDEXX Legiolert test was compared to the Dutch national reference technique for detecting Legionella pneumophila in the research.
  • A two-day free virtual conference on legionnaires' disease hazards during and after a covid-19 pandemic was held by the Alliance to Prevent Legionnaires' Disease, a national nonprofit organisation, in August 2020. This virtual conference aimed to increase public awareness of the effective management of risk factors associated with watery Legionnaires' disease.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth rate

CAGR of 9% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD Million and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Product type, diagnostic test, end user, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; F. Hoffmann-La Roche AG; Thermo Fischer Scientific, Inc.; Becton, Dickinson and Company; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs.

 Key Segments For Legionnaire Disease Testing Market

Legionnaire Disease Testing Segmentation by Product Type:

  • Devices
  • Polymerase Chain Reaction System
  • Sequencer System
  • Test Kits
  • Assay Based Test Kits
  • Rapid Test Kits

Legionnaire Disease Testing Segmentation by Diagnostic Test:

  • Culture Method
  • Urinary Antigen Test
  • Paired Serology
  • Direct Fluorescent Antibody (DFA) Stain
  • Polymerase Chain Reaction (PCR)
  • Combination Testing (Culture and Urinary Antigen Tests)

Legionnaire Disease Testing Segmentation by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Clinical Research Centers
  • Academic Institutes
  • Research Centers
  • Others

Legionnaire Disease Testing Segmentation by Region:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Frequently Asked Questions

The legionnaire disease testing market is predicted to register a CAGR of 9% during the forecast period.

Key players holding substantial legionnaire disease testing market share include Beckman Coulter, Inc.; Albagaia Ltd.; Bio-Rad Laboratories, Inc.; Abbott Laboratories.; Aquacert Ltd, BioMérieux SA; Idexx Laboratories Inc.; and others

As per the analysis, the legionnaire disease testing market share is likely to be US$ 411.3 Mn by 2026.

Demand for legionnaire disease testing is likely to rise being driven by an increase in the need for better diagnostic methods as the prevalence rate rises.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Devices

        5.3.2. Polymerase Chain Reaction System

        5.3.3. Sequencer System

        5.3.4. Test Kits

        5.3.5. Assay Based Test Kits

        5.3.6. Rapid Test Kits

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Diagnostic Test

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Diagnostic Test, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Diagnostic Test, 2022-2032

        6.3.1. Culture Method

        6.3.2. Urinary Antigen Test

        6.3.3. Paired Serology

        6.3.4. Direct Fluorescent Antibody Stain

        6.3.5. Polymerase Chain Reaction

        6.3.6. Combination Testing

    6.4. Y-o-Y Growth Trend Analysis By Diagnostic Test, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Diagnostic Test, 2022-2032

7. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Diagnostic Laboratories

        7.3.3. Clinical Research Centers

        7.3.4. Academic Institutes

        7.3.5. Research Centers

        7.3.6. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia & Pacific

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Diagnostic Test

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Diagnostic Test

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Mexico

            10.2.1.2. Brazil

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Diagnostic Test

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Diagnostic Test

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. BENELUX

            11.2.1.7. Russia

            11.2.1.8. Rest of Europe

        11.2.2. By Product Type

        11.2.3. By Diagnostic Test

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Diagnostic Test

        11.3.4. By End User

    11.4. Key Takeaways

12. East Asia Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Product Type

        12.2.3. By Diagnostic Test

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Diagnostic Test

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia & Pacific Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Australia and New Zealand

            13.2.1.4. Rest of South Asia & Pacific

        13.2.2. By Product Type

        13.2.3. By Diagnostic Test

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Diagnostic Test

        13.3.4. By End User

    13.4. Key Takeaways

14. MEA Legionnaire Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Turkey

            14.2.1.3. South Africa

            14.2.1.4. Rest of MEA

        14.2.2. By Product Type

        14.2.3. By Diagnostic Test

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Diagnostic Test

        14.3.4. By End User

    14.4. Key Takeaways

15. Key Countries Legionnaire Disease Testing Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Product Type

            15.1.2.2. By Diagnostic Test

            15.1.2.3. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Product Type

            15.2.2.2. By Diagnostic Test

            15.2.2.3. By End User

    15.3. Mexico

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Product Type

            15.3.2.2. By Diagnostic Test

            15.3.2.3. By End User

    15.4. Brazil

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Product Type

            15.4.2.2. By Diagnostic Test

            15.4.2.3. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Product Type

            15.5.2.2. By Diagnostic Test

            15.5.2.3. By End User

    15.6. Italy

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Product Type

            15.6.2.2. By Diagnostic Test

            15.6.2.3. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Product Type

            15.7.2.2. By Diagnostic Test

            15.7.2.3. By End User

    15.8. U.K.

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Product Type

            15.8.2.2. By Diagnostic Test

            15.8.2.3. By End User

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Product Type

            15.9.2.2. By Diagnostic Test

            15.9.2.3. By End User

    15.10. BENELUX

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Product Type

            15.10.2.2. By Diagnostic Test

            15.10.2.3. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Product Type

            15.11.2.2. By Diagnostic Test

            15.11.2.3. By End User

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Product Type

            15.12.2.2. By Diagnostic Test

            15.12.2.3. By End User

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Product Type

            15.13.2.2. By Diagnostic Test

            15.13.2.3. By End User

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Product Type

            15.14.2.2. By Diagnostic Test

            15.14.2.3. By End User

    15.15. India

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Product Type

            15.15.2.2. By Diagnostic Test

            15.15.2.3. By End User

    15.16. ASEAN

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Product Type

            15.16.2.2. By Diagnostic Test

            15.16.2.3. By End User

    15.17. Australia and New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Product Type

            15.17.2.2. By Diagnostic Test

            15.17.2.3. By End User

    15.18. GCC Countries

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Product Type

            15.18.2.2. By Diagnostic Test

            15.18.2.3. By End User

    15.19. Turkey

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Product Type

            15.19.2.2. By Diagnostic Test

            15.19.2.3. By End User

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Product Type

            15.20.2.2. By Diagnostic Test

            15.20.2.3. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By Diagnostic Test

        16.3.4. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Beckman Coulter, Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Bio-Rad Laboratories, Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Abbott Laboratories.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. F. Hoffmann-La Roche AG

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Thermo Fischer Scientific, Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Becton, Dickinson and Company

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Aquacert Ltd

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. BioMérieux SA

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Idexx Laboratories Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Legionnaire Disease Testing Market Volume (Units) Forecast by Region, 2017-2032

Table 3: Global Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 4: Global Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 5: Global Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 6: Global Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 7: Global Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 8: Global Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Table 9: North America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: North America Legionnaire Disease Testing Market Volume (Units) Forecast by Country, 2017-2032

Table 11: North America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 12: North America Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 13: North America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 14: North America Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 15: North America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: North America Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Table 17: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Latin America Legionnaire Disease Testing Market Volume (Units) Forecast by Country, 2017-2032

Table 19: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 20: Latin America Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 21: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 22: Latin America Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 23: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 24: Latin America Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Table 25: Europe Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: Europe Legionnaire Disease Testing Market Volume (Units) Forecast by Country, 2017-2032

Table 27: Europe Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 28: Europe Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 29: Europe Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 30: Europe Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 31: Europe Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 32: Europe Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Table 33: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 34: East Asia Legionnaire Disease Testing Market Volume (Units) Forecast by Country, 2017-2032

Table 35: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 36: East Asia Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 37: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 38: East Asia Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 39: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 40: East Asia Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Table 41: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 42: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Forecast by Country, 2017-2032

Table 43: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 44: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 45: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 46: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 47: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 48: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Table 49: MEA Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 50: MEA Legionnaire Disease Testing Market Volume (Units) Forecast by Country, 2017-2032

Table 51: MEA Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 52: MEA Legionnaire Disease Testing Market Volume (Units) Forecast by Product Type, 2017-2032

Table 53: MEA Legionnaire Disease Testing Market Value (US$ Mn) Forecast by Diagnostic Test, 2017-2032

Table 54: MEA Legionnaire Disease Testing Market Volume (Units) Forecast by Diagnostic Test, 2017-2032

Table 55: MEA Legionnaire Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 56: MEA Legionnaire Disease Testing Market Volume (Units) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 2: Global Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 3: Global Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Legionnaire Disease Testing Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Legionnaire Disease Testing Market Volume (Units) Analysis by Region, 2017-2032

Figure 7: Global Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: Global Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: Global Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 10: Global Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 11: Global Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 12: Global Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 13: Global Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 14: Global Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 15: Global Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 16: Global Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 17: Global Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 18: Global Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 19: Global Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 20: Global Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 21: Global Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 22: Global Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 23: Global Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 24: Global Legionnaire Disease Testing Market Attractiveness by Region, 2022-2032

Figure 25: North America Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 26: North America Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 27: North America Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 28: North America Legionnaire Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 29: North America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 30: North America Legionnaire Disease Testing Market Volume (Units) Analysis by Country, 2017-2032

Figure 31: North America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 32: North America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 33: North America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 34: North America Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 35: North America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 36: North America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 37: North America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 38: North America Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 39: North America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 40: North America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 41: North America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 42: North America Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 43: North America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 44: North America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 45: North America Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 46: North America Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 47: North America Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 48: North America Legionnaire Disease Testing Market Attractiveness by Country, 2022-2032

Figure 49: Latin America Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 50: Latin America Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 51: Latin America Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 52: Latin America Legionnaire Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Latin America Legionnaire Disease Testing Market Volume (Units) Analysis by Country, 2017-2032

Figure 55: Latin America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 56: Latin America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 57: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 58: Latin America Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 59: Latin America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 60: Latin America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 61: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 62: Latin America Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 63: Latin America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 64: Latin America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 65: Latin America Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 66: Latin America Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 67: Latin America Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 68: Latin America Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 69: Latin America Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 70: Latin America Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 71: Latin America Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 72: Latin America Legionnaire Disease Testing Market Attractiveness by Country, 2022-2032

Figure 73: Europe Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 74: Europe Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 75: Europe Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 76: Europe Legionnaire Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 77: Europe Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 78: Europe Legionnaire Disease Testing Market Volume (Units) Analysis by Country, 2017-2032

Figure 79: Europe Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 80: Europe Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 81: Europe Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 82: Europe Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 83: Europe Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 84: Europe Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 85: Europe Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 86: Europe Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 87: Europe Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 88: Europe Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 89: Europe Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 90: Europe Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 91: Europe Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 92: Europe Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 93: Europe Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 94: Europe Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 95: Europe Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 96: Europe Legionnaire Disease Testing Market Attractiveness by Country, 2022-2032

Figure 97: East Asia Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 98: East Asia Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 99: East Asia Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 100: East Asia Legionnaire Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 101: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 102: East Asia Legionnaire Disease Testing Market Volume (Units) Analysis by Country, 2017-2032

Figure 103: East Asia Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 104: East Asia Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 105: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 106: East Asia Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 107: East Asia Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 108: East Asia Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 109: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 110: East Asia Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 111: East Asia Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 112: East Asia Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 113: East Asia Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 114: East Asia Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 115: East Asia Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: East Asia Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: East Asia Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 118: East Asia Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 119: East Asia Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 120: East Asia Legionnaire Disease Testing Market Attractiveness by Country, 2022-2032

Figure 121: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 122: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 123: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 124: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 125: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Analysis by Country, 2017-2032

Figure 127: South Asia & Pacific Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 128: South Asia & Pacific Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 129: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 130: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 131: South Asia & Pacific Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 132: South Asia & Pacific Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 133: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 134: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 135: South Asia & Pacific Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 136: South Asia & Pacific Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 137: South Asia & Pacific Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 138: South Asia & Pacific Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 139: South Asia & Pacific Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 140: South Asia & Pacific Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 141: South Asia & Pacific Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 142: South Asia & Pacific Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 143: South Asia & Pacific Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 144: South Asia & Pacific Legionnaire Disease Testing Market Attractiveness by Country, 2022-2032

Figure 145: MEA Legionnaire Disease Testing Market Value (US$ Mn) by Product Type, 2022-2032

Figure 146: MEA Legionnaire Disease Testing Market Value (US$ Mn) by Diagnostic Test, 2022-2032

Figure 147: MEA Legionnaire Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 148: MEA Legionnaire Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 149: MEA Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 150: MEA Legionnaire Disease Testing Market Volume (Units) Analysis by Country, 2017-2032

Figure 151: MEA Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 152: MEA Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 153: MEA Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 154: MEA Legionnaire Disease Testing Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 155: MEA Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 156: MEA Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 157: MEA Legionnaire Disease Testing Market Value (US$ Mn) Analysis by Diagnostic Test, 2017-2032

Figure 158: MEA Legionnaire Disease Testing Market Volume (Units) Analysis by Diagnostic Test, 2017-2032

Figure 159: MEA Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by Diagnostic Test, 2022-2032

Figure 160: MEA Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by Diagnostic Test, 2022-2032

Figure 161: MEA Legionnaire Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 162: MEA Legionnaire Disease Testing Market Volume (Units) Analysis by End User, 2017-2032

Figure 163: MEA Legionnaire Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 164: MEA Legionnaire Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 165: MEA Legionnaire Disease Testing Market Attractiveness by Product Type, 2022-2032

Figure 166: MEA Legionnaire Disease Testing Market Attractiveness by Diagnostic Test, 2022-2032

Figure 167: MEA Legionnaire Disease Testing Market Attractiveness by End User, 2022-2032

Figure 168: MEA Legionnaire Disease Testing Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Veterinary Infectious Disease Diagnostics Market

Published : February 2022

Healthcare

Addison Disease Testing Market

Published : July 2017

Healthcare

Septicemia Diagnostic Testing Market

Published : January 1970

Healthcare

Infectious Disease Diagnostics Market

Published : January 2016

Google translate

Legionnaire Disease Testing Market